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Lewy body formation within the bralnstem, neo-, and limbic cortices with senile plaque formation and sparse neurofibrillary tangles (Kuzuhara & Yoshimura, 1993; Perry, Irving, Blessed, Fairbairn, & Perry, 1990) . Diffuse cortical Lewy bodies are frequently found in association with senile plaques, and have been shown to result in dementia even in the absence of concomitant senile changes (Kosaka, 1993) .
While one of the first reports of Lewy bodies being associated with a specific dementia was in 1962 (Woodard, 1962) , it has been only in recent years that the clinical features and prognosis of Lewy body disease have been defined. These efforts have met with substantial contradiction. For example, McKeith, Perry, Fairbaim, Jabeen, and Perry (1992) retrospectively rated case notes of autopsy-proven diffuse cortical Lewy body disease and reported the cardinal feature to be a course of fluctuating cognitive impairment, followed in frequency by psychotic features with visual and auditory hallucinations, paranoid and depressive symptoms, and unexplained falling. Similarly, Kuzuhara and Yoshimura (1993) reported on eight autopsy-verified cases of diffuse Lewy body disease and found dementia to be the cardinal symptom, followed in frequency by hallucinatory-delusional state, akinesia and rigidity, orthostatic hypotension, and amnesia.
In contrast, Hansen et al. (1990) reported that the development of dementia in Lewy body disease was quite similar to Alzheimer's disease in terms of an insidious onset, progression, survival to death, as well as frequency of symptoms of forgetfulness, getting lost, personality change, and delusions in the 13 patients they had studied. Based on objective detailed neurocognitive evidence comparing nine matched Alzheimer's and nine diffuse Lewy body disease patients, they reported that the diffuse Lewy body patients had greater deficits in attention, fluency, and visuospatial processing. Psychiatric symptoms were reported as rare in both groups. The diffuse Lewy body patients showed increased masked facies, essential tremor, bradykinesia, neck rigidity, and slowing of rapidly alternating movements without extremity rigidity, flexed posture, resting tremor, or other parkinsonian features.
Methodological differences in case selection and retrospective case note analysis may account for some of the discrepancies in the literature. Wide variability in disease expression and need for further subtyping may account for further variability. For example, the method of screening cases for study may influence subsequent findings. Subject selection has been based on cases referred posthumously for neuropathological study known to have "dementia" (Gibb, Luthert, Janota, & Lantos, 1989) ; cases who were known to suffer from dementia, extrapyramidal syndrome, or both (Byrne, Lennox, Lowe, & Godwin-Austen, 1989) ; cases that had been referred for psychogeriatric assessment and later came to autopsy ; cases neuropathologically diagnosed out of consecutive autopsies (Kuzuhara & Yoshimura, 1993) ; and cases meeting the NINCDS-ADRDA (MaKhann et al., 1984) criteria for Alzheimer's disease that came to neuropathological study (Hansen et al., 1990) . Other methodological differences include efforts to characterize clinical features based on a clinical diagnosis that has not been biopsy or autopsy confirmed (Sahgal et al., 1992) .
Generally speaking, the neurocognitive characterization of the clinical course has been restricted as a function of retrospective case note analysis with little-to-no objective documentation of mental function. Only Hansen et al. (1990) used comprehensive neurocognitive data to characterize the clinical features as a part of ongoing longitudinal study on Alzheimer's disease, but this study has been criticized on the basis of subject selection and lack of presentation in their serial data.
Diffuse Lewy body disease has been described in individuals ranging in age from 27 years (Opeskin, Gonzales, & Borenstein, & Anderson, 1993) to 92 years (Kuzuhara & Yoshimura, 1993) . The course has been described as rapidly progressive over 3 months (Armstrong et al., 1991) , to not significantly different from Alzheimer's disease (Hansen et al., 1990) . The clinical features are variable, as previousl X described, and management of symptoms has produced mixed findings. McKeith, Fairbaim, Perry, Thompson, and Perry (1993) reported extreme sensitivity to neuroleptics with 81% of the cases showing adverse and often irreversible reactions. However, Chacko, Hurley, and Jankovic (1993) have reported a favorable response in one case with Clozapine. There is a report of three successful "responders" to the cholinesterase inhibitor tacrine (Levy et al., 1994) .
The natural history and clinical expression of diffuse Lewy body disease is not well understood. The purpose of this article was to provide a detailed prospective study of an individual with diffuse Lewy body disease. Serial neuropsychometric measures highlight the unique aspects of this incidious progressive dementia, which appears distinquishable from degenerative dementias of the Alzheimer's type.
METHOD

Subject
The case was a 60-year-old Caucasian male who was clinically followed in a universitybased Memory Disorder Clinic over a 24-month period. He had no prior medical history and there was no family history of neurologic or psychiatric disorders. He was married, college educated, and ran a family-owned insurance/real estate business until shortly after the onset of his symptoms.
Measures
All medical procedures were conducted according to university hospital standard of care by board certified specialists. In terms of neurocognitive measures, there is considerable debate, and no consensus, on the selection of tests to screen for dementia. The NINCDS/ADRDA Task Force (McKhann et al., 1984) recommended the broad principle of selecting tests capable of detecting measurable abnormalities in two or more aspects of cognition. However, while NINCDS/ADRDA standard of care emphasizes only detection of cognitive impairment sufficient to meet the criteria of dementia, it is clear that not all dementias are created equal, and that detailed neuropsychological measurement can aid in distinquishing different types of dementia (Weintraub & Mesulam, 1994) .
For this study, the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) was selected as a known standardized battery for assessing dementia (Morris et al., 1989; Welsh et al., 1994) . Other widely used measures were used, selected on the basis of their ability to sample a wide range of higher cortical function. All measures were administered according to published procedures and included the Wechsler Adult Intelligence ScaleRevised (WAIS-R; Wechsler, 1981) , Wechsler Memory Scale with the Russell Revision (WMS; Russell, 1988) , the Information and Orientation subtest from the Wechsler Memory Scale-Revised (Wechsler, 1987) , the Trail Making test (Reitan & Wolfson, 1985) , Visual Organization Test (VOT; Hooper, 1985) , Draw-a-Clock test , Behavioral Dyscontrol Scale (Grigsby, Kaye, & Robbins, 1992) , Boston Naming Test (Kaplan, Goodglass, & Weintraub, 1983) , and Mini-Mental State Exam (MMSE) score (Folstein, Folstein, & McHugh, 1975) . Two rating scales were used and included the Clinical Dementia Rating (CDR) staging (Berg, 1988; Hughes, Berg, Danziger, Coben, & Martin, 1982) and Memory and Behavior Problem Checklist (Teri, Truax, Logsdon, Uomoto, Zarit, & Vitaliano, 1992) . Some tests were repeated, while other tasks became too difficult for the patient to warrant readministration.
Of these tests, the CERAD may be the least well known. The CERAD neuropsychological test battery is a brief series of measures used to characterize the cognitive manifestations of AD. This measure is widely used at many AD research centers and has been found to have acceptable properties of reliability and validity, especially for serial measurement of AD patients (Morris et al., 1989) . The Clinical Dementia Rating (CDR) scale (Berg, 1988; Hughes et al., 1982) also is not well known, but is a method of global staging of dementia. The ratings of degree of impairment in six categories of cognitive function are synthesized into one global rating of dementia severity. This measure has been found to have acceptable properties of reliability (Burke et al., 1988) .
Procedure
The patient was clinically followed over a 24-month period. He underwent extensive serial metabolic, neuroradiographic, and neuropsychologic study. Neuropsychometric studies were conducted at 6, 10, 12, and 24 months into his disease course. Twelve months into the disease course he underwent a brain biopsy that provided pathologic confirmation of disease type. Last, his response to an experimental trial of Tacrine was introduced during month 14 and withdrawal during month 18.
RESULTS
Disease Course
The patient first presented for neurologic evaluation with complaints of a progressive 6-month history of significant confusion and concentration problems that interfered with his ability to work. He also complained of minor "jerks" of his right hand, which his wife noted were especially noticeable just prior to sleep. Unusual behaviors noted by his wife included not being able to communicate effectively. She also reported that he was no longer able to understand the rules of football on television inspite of premorbidly being a devote sports fan. His wife observed that he had made several inappropriate public verbal sexual overtures that were quite embarrassing to her. Finally, she noted that he occasionally complained of objects appearing to flicker or move. She denied that he had a specific focal disturbance in short-term memory.
About 10 months into the disease course, the patient's wife noted that general confusion, vivid nightmares, and occasional hallucinations were most problematic and, again, denied a specific focal short-term memory disturbance. She stated that visual hallucinations had worsened. Reportedly, he would "see stationary objects move and indoor lights appear to blink, when they do not." She also noted "his hands, body, and legs jerk or twitch when he sits still or when he falls asleep."
During months 14 to 18, the patient's response to tacrine was monitored. During this time, his wife reported that he slept restlessly and would awaken in the morning unable to differentiate dreams from reality. His memory of the dreams were vivid and he would talk about them throughout the day. She reported that he began to have difficulty recognizing her and his son.
Twenty-four months into the disease course, his wife reported remarkable fluctuations in his mental status, with periods of normal orientation and occasional understanding of television sports, such that he has even been able to discuss a team's relative standing. She reported that his memory continued to be relatively preserved. As examples, she stated that when the patient was taken to parties, he would ask specifically about people by name. He also would frequently talk about his son's pending wedding plans. He continued to remember the name of his nurse's aide, but confused his wife with his daughter and vise versa. He reportedly wandered excessively, bumping into doors, walls, and had profound hallucinations regularly. On one occasion while preparing for bed, he roughly pushed his wife away because he thought he was driving a car. Finally, it was reported that in the bathroom he confused the shower and the commode and has been stopped from trying to step into the commode to bathe. Because of progressive management problems, his wife was considering nursing home placement at the last follow-up examination.
Neurologic and Laboratory Findings
Six months into the course, a general neurologic examination was unremarkable except for mild volitional dysmetria. Symptoms progressed to mild cogwheel rigidity, mild static tremor with hands outstretched, and a positive snout reflex. Bilateral myoclonic jerks emerged early in the disease course, but remained relatively unchanged. Bradykinesia did not occur until late in the course.
Metabolic studies were unremarkable throughout the disease course. Two EEG studies were abnormal with moderately diffuse slowing in the background activity with rare, sharply formed waves. Two MRI studies showed minor cortical atrophy with questionable prominence in the frontal areas. A neuroSPECT study revealed a decrease in activity in the posterior temporoparietal region bilaterally, consistent with Alzheimer's disease.
Neuropathologic Investigation
A specimen of a 2 cm 2 biopsy specimen of the right frontal dura and cortical tissue was taken. The pathology report found diffuse neuritic plaques predominating particularly in the upper cortical layers. Neurofibrillary tangles and neuropil threads were not observed, but cortical Lewy-body structures were found in the deeper cortical layers. The diagnostic conclusion was: "Lewy body variant of Alzheimer's disease or diffuse Lewy body disease, depending on the nonstandard nomenclature currently in use."
Neuropsychological Investigation
During the patient's disease course, he underwent four neurocognitive examinations. The findings of the serial neurocognitive investigations showed an atypical, rapidly progressive dementia (see Table 1 ). In particular, the patient showed a pattern of profound intellectual (Wechsler, 1981) decline over a 24-month interval. Atypical of AD, simple psychomotor speed as measured by Digit Symbol (Wechsler, 1981) and Trails A (Reitan & Wolfson, 1985) was disproportionately affected early in the course. While immediate and delayed verbal and figural memory (Russell, 1988) was weak throughout the course, a pattern of a focal progressive disturbance in memory as is typically seen in AD was not evident. This finding was further ecologically validated by the wife's report and responses on the Memory and Behavior Problem Checklist (Ted et al., 1992) where deficits in day-to-day memory were not the prominent symptom. Instead, reports of behavioral dyscontrol and hallucination were most problematic. Information and orientation questions (Wechsler, 1987) were remarkably preserved throughout much of the patient's disease course, which is atypical of AD. Lastly, perseverative motoric behavior measured at 10 months into the course yielded a score of 5 on the Behavioral Dyscontrol Scale (Grigsby et al., 1992) , which falls into the "Severe" range. Likewise, throughout the course, there was qualitative evidence of perseverative motor graphic responding , which worsened as his disease progressed (see Figure 1) . aWAIS-R subtests reported as age-corrected scale scores. b'W-MS scores are reported as raw scores. cOrientation questions were from the WMS personal/current information and orientation or WMS-R information and orientation subtests (at month 12, only 10 items were administered).
Attempts to score the patient on the Clinical Dementia Rating (CDR) staging (Hughes et al., 1982) at 10 months into the disease course also showed a highly variable and atypical pattern unlike that of Alzheimer's disease patients, who tend to show equal degrees of disturbance in each dimension (Berg, 1988) . Specifically, the patient showed no disturbance in orientation (coded as 0), a mild disturbance in memory and personal care (coded as 1), and a moderate disturbance in judgement, community affairs, and hobbies (coded as a 2), yielding an overall CDR score of 2.0 or "Moderate Dementia." At 24 months, his condition progressed to 3.0 or "Severe Dementia," with similar scatter and the previously noted fluctuations in course.
Qualitatively, the patient's behavior initially was characterized by confusion and occasional bilateral myoclonic jerks. Visuographic performance showed early perseverative motor graphic responses that worsened. Language initially included occasional paraphasic errors in his running speech, but evolved to frequent semantic paraphasic errors. Late in the course, his affect ranged from a blank stare to inappropriate laughter.
Treatment
After pathologic biopsy confirmation of disease type, the patient was started on an experimental trial of tacrine at 40 mg/qd dose, which was increased to 80 mg/qd after 5 weeks. He did not respond favorably to tacrine even though his liver enzymes were unaffected. Confusion, myoclonic jerks, and vivid visual hallucinations increased. After discontinuation of the tacrine, there was a decrease in myoclonus, nightmares, and his confusion improved slightly. The patient's neurocognitive function continued to decline and he required extensive supervision in his home environment.
DISCUSSION
This article uniquely contributes to the understanding of the syndrome expression of diffuse Lewy body disease by providing a detailed prospective clinical and serial neuropsychological description of a biopsy-proven case. Unique neuropsychological features that distinguish this disorder from other neurodegenerative disorders such as Alzheimer's disease are highlighted. Secondly, specific aspects of this case for which there is limited reference, include detailed clinical description of an unusually aggressive course, detailed serial objective neurocognitive data, and biopsy confirmation of the disease type. Finally, and contrary to one previous report, an adverse response to tacrine was reported.
This type of serial neuropsychological description has been scarce in the literature. To date, most cases have been autopsy identified, and furthermore, have been clinical descriptions based on retrospective review of clinical chart notes for which little-to-no objective measurement of neurocognitive function has been conducted. This case also illustrates the wide variability of case descriptions by highlighting many "typical" and "atypical" neurobehavioral features that appear to characterize this degenerative disease process. Finally, an adverse response to a trial of tacrine was noted.
Clinical highlights of this patient's disease course began with peculiar problems of confusion, minor hallucinations, and odd behaviors. There was no specific observation by patient or wife, nor neuropsychometric confirmation of a prominent focal progressive memory disturbance as is characteristically seen in AD. Similarly, measures of motor behavior, which are typically unaffected in AD, were noteworthy even in the initial presentation. Likewise, visuographic perseveration and behavioral dyscontrol were notable early in the course. Consistent with Hansen et al.'s (1990) report of visuoperceptual disturbance in Lewy body disease, this patient also showed a disproportional involvement of a markedly impaired WAIS-R Block Design subtest score at the initial examination. Finally, another unique feature highly atypical of Alzheimer's disease was the patient's almost completely preserved orientation until late in his course.
In terms of the disease course, this case is similar to some reports (Hansen et al., 1990 ), but atypical of other reports (Gibbet al., 1989; McKeith et al., 1992) ; there was not a remarkable fluctuating course (until late in the disease), and extrapyramidal signs were minimal. Likewise, the patient did show marked visual distortions, hallucinations, and vivid nightmares throughout much of his course. This finding is consistent with most descriptions (Byrne et al., 1989; Gibbet al., 1989; McKeith et al., 1992) , but is contrary to the findings of another major study (Hansen et al., 1990) .
Whether inconsistencies in the literature related to the syndrome description are due to methodological differences and/or an underlying continuum of disease subtypes remains unresolved and will require further study. Nevertheless, the literature to date is convincing in that diffuse Lewy body disease is a unique clinicopathological entity. There is likewise now support in the literature of a unique neurobehavioral syndrome expression (Hanson et al., 1990; McKeith et al., 1994) .
Based on our detailed clinical interviews and serial neurocognitive examination, we were able to distinguish this case from that of Alzheimer's disease with some confidence, even at the time of the initial presentation. While a diagnosis of Alzheimer's disease was on our differential list primarily because of the degenerative course, it was thought to be of low probability because of the patient's highly atypical clinical course and neurocognitive features. Even the neuroSPECT finding of bilateral temporoparietal hypoperfusion was unconvincing in light of the highly atypical serial neurocognitive data.
As a note of caution, while our case showed very typical pathological features of diffuse Lewy body disease (or Lewy body variant of Alzheimer's disease), our case did have the atypical feature of rapid disease progression. Whether this affects the generalizability of these findings to other cases or represents a specific disease subtype remains to be resolved.
